Arcutis Biotherapeutics, Inc. SEC filings ARQT

Arcutis Biotherapeutics, Inc. has 866 filings in SEC EDGAR's recent list, going back to Sep 9, 2019. Its latest annual report, Form ARS, was filed on Apr 21, 2026 for the period ended Apr 21, 2026. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.

Arcutis Biotherapeutics, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 4, 2026 Nov 2, 2026
3 Initial insider ownership Nov 4, 2026 Nov 4, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
3/A Form 3/a Nov 4, 2026 Oct 23, 2026
4 Insider transaction Nov 4, 2026 Nov 2, 2026
144 Notice of proposed sale Nov 4, 2026 —
424B5 Prospectus supplement Nov 4, 2026 —
10-Q Quarterly report Nov 4, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 4, 2026 Nov 4, 2026
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
144 Notice of proposed sale Nov 2, 2026 —
3 Initial insider ownership Oct 28, 2026 Oct 23, 2026
4 Insider transaction Oct 28, 2026 Oct 23, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Oct 28, 2026 Oct 23, 2026
144 Notice of proposed sale Oct 20, 2026 —
4 Insider transaction Oct 19, 2026 Oct 15, 2026
144 Notice of proposed sale Oct 15, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 5, 2026 —
4 Insider transaction Sep 18, 2026 Sep 16, 2026
4 Insider transaction Sep 17, 2026 Sep 15, 2026
144 Notice of proposed sale Sep 16, 2026 —
144 Notice of proposed sale Sep 15, 2026 —
4 Insider transaction Sep 10, 2026 Sep 8, 2026
144 Notice of proposed sale Sep 8, 2026 —
4 Insider transaction Aug 28, 2026 Aug 27, 2026
144 Notice of proposed sale Aug 27, 2026 —
4 Insider transaction Aug 24, 2026 Aug 20, 2026
4 Insider transaction Aug 21, 2026 Aug 19, 2026
144 Notice of proposed sale Aug 20, 2026 —
4 Insider transaction Aug 19, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 19, 2026 —
144 Notice of proposed sale Aug 17, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 14, 2026 —
4 Insider transaction Aug 13, 2026 Aug 11, 2026
144 Notice of proposed sale Aug 11, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Aug 7, 2026 —
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
10-Q Quarterly report Aug 5, 2026 Jun 30, 2026
8-K Current report
Results of operations, Officer or director change
Aug 5, 2026 Jul 31, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
4 Insider transaction Jul 17, 2026 Jul 15, 2026
3 Initial insider ownership Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Jul 16, 2026 Jul 15, 2026
144 Notice of proposed sale Jul 15, 2026 —
4 Insider transaction Jun 17, 2026 Jun 15, 2026
4 Insider transaction Jun 17, 2026 Jun 15, 2026
144 Notice of proposed sale Jun 17, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
144 Notice of proposed sale Jun 15, 2026 —
4/A Form 4/a Jun 12, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
4 Insider transaction Jun 9, 2026 Jun 5, 2026
8-K Current report
Shareholder vote results, Other events
Jun 9, 2026 Jun 5, 2026
4 Insider transaction May 13, 2026 May 11, 2026
4 Insider transaction May 13, 2026 May 11, 2026
SCHEDULE 13G Ownership over 5% (passive) May 12, 2026 —
144 Notice of proposed sale May 11, 2026 —
144 Notice of proposed sale May 11, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2026 —
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
4 Insider transaction May 6, 2026 May 4, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 6, 2026 —
10-Q Quarterly report May 6, 2026 Mar 31, 2026
8-K Current report May 6, 2026 May 6, 2026
4 Insider transaction May 5, 2026 May 1, 2026
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 4, 2026 —
144 Notice of proposed sale May 1, 2026 —
S-8 Employee stock plan registration Apr 21, 2026 —
ARS Annual report to shareholders Apr 21, 2026 Apr 21, 2026
DEFA14A Additional proxy material Apr 21, 2026 —
DEF 14A Proxy statement Apr 21, 2026 Apr 21, 2026
4 Insider transaction Apr 3, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Feb 27, 2026
4 Insider transaction Mar 3, 2026 Aug 18, 2022
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
S-8 Employee stock plan registration Feb 25, 2026 —
S-3ASR Automatic shelf registration Feb 25, 2026 —
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2026 —
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
4 Insider transaction Feb 4, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 4, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 30, 2026 —
4 Insider transaction Jan 7, 2026 Jan 5, 2026
4 Insider transaction Jan 6, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 5, 2026 —
4 Insider transaction Jan 2, 2026 Dec 31, 2025
144 Notice of proposed sale Jan 2, 2026 —
144 Notice of proposed sale Dec 31, 2025 —
4 Insider transaction Dec 17, 2025 Dec 15, 2025
144 Notice of proposed sale Dec 15, 2025 —
4 Insider transaction Dec 8, 2025 Dec 4, 2025
3 Initial insider ownership Dec 8, 2025 Dec 4, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Dec 8, 2025 Dec 3, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
4 Insider transaction Dec 3, 2025 Dec 1, 2025
UPLOAD Letter from the SEC Dec 2, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
144 Notice of proposed sale Dec 1, 2025 —
4 Insider transaction Nov 25, 2025 Nov 24, 2025
4 Insider transaction Nov 24, 2025 Nov 21, 2025
144 Notice of proposed sale Nov 24, 2025 —
144 Notice of proposed sale Nov 24, 2025 —
4 Insider transaction Nov 21, 2025 Nov 19, 2025
4 Insider transaction Nov 21, 2025 Nov 20, 2025
144 Notice of proposed sale Nov 21, 2025 —
144 Notice of proposed sale Nov 20, 2025 —
144 Notice of proposed sale Nov 19, 2025 —
4 Insider transaction Nov 17, 2025 Nov 13, 2025
4 Insider transaction Nov 17, 2025 Nov 13, 2025
144 Notice of proposed sale Nov 13, 2025 —
4 Insider transaction Nov 10, 2025 Nov 6, 2025
4 Insider transaction Nov 10, 2025 Nov 6, 2025
144 Notice of proposed sale Nov 6, 2025 —
144/A Filing Nov 6, 2025 —
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
4 Insider transaction Nov 5, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 5, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
144 Notice of proposed sale Nov 3, 2025 —
4 Insider transaction Oct 30, 2025 Oct 28, 2025
144 Notice of proposed sale Oct 28, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
CORRESP Letter to the SEC Oct 10, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 6, 2025 —
4 Insider transaction Oct 6, 2025 Oct 2, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
4 Insider transaction Oct 3, 2025 Oct 1, 2025
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 2, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
144 Notice of proposed sale Oct 1, 2025 —
UPLOAD Letter from the SEC Sep 15, 2025 —
4 Insider transaction Sep 10, 2025 Sep 8, 2025
144 Notice of proposed sale Sep 9, 2025 —
4 Insider transaction Sep 8, 2025 Sep 4, 2025
144 Notice of proposed sale Sep 8, 2025 —
4 Insider transaction Sep 4, 2025 Sep 2, 2025
144 Notice of proposed sale Sep 4, 2025 —
144 Notice of proposed sale Sep 2, 2025 —
4 Insider transaction Aug 21, 2025 Aug 19, 2025
144 Notice of proposed sale Aug 21, 2025 —
SCHEDULE 13D/A Amended ownership over 5% (active) Aug 20, 2025 —
144 Notice of proposed sale Aug 19, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 12, 2025 Aug 8, 2025
144 Notice of proposed sale Aug 8, 2025 —
144 Notice of proposed sale Aug 8, 2025 —
10-Q Quarterly report Aug 6, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 6, 2025 Aug 6, 2025
144 Notice of proposed sale Aug 6, 2025 —

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ARQT (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Westlake Village, CA
SEC filer status
Large accelerated filer
SEC CIK
1787306
Former names
Arcutis, Inc. (until Sep 9, 2019)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.